Therapeutic Respiratory Devices Market 2018: Global Industry Top key Players – GE Healthcare, Hamilton Medical, Philips Healthcare, Aircep Corporation, Breas Medical, CareFusion Corporation, Inogen, Invacare, Medtronic, Mindray Medical

Market Study Report recently introduced new title on “2018-2024 Global Therapeutic Respiratory Devices Market Report” that provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2024.

Therapeutic Respiratory Devices Market will exceed USD 21.5 billion by 2024; as per a new research report. Growing elderly population base worldwide will drive therapeutic respiratory devices market growth over the forecast timeframe. Geriatric population are prone to chronic disease owing to age related structural changes, changes in ventilatory response as well as pulmonary functions. Increasing prevalence of chronic diseases such as asthma, COPD, bronchitis and other respiratory disorders among the elderly population base across the world will stimulate the industry growth over the coming years.

Request a sample of this premium report at https://www.marketstudyreport.com/request-a-sample/467771/

Increasing investments in research for development of advanced and innovative devices will serve to be another positive impact rendering factor. Developments in therapeutic respiratory devices offer advanced features such as high efficiency, high portability, easy-to-use, smart and light weight devices. Increasing focus of industry players on developing newer technologies will fuel the demand for respiratory devices thereby augmenting industry growth. However, lack of patient constancy to the treatment owing to inconvenience caused during the use of these devices will hamper the growth of therapeutic respiratory devices market.

Ventilator segment is expected to generate revenue of USD 2.2 billion in 2024, owing to the rising number of surgeries being performed worldwide. Rising number of preterm births, increasing prevalence of chronic pulmonary and respiratory diseases will further accelerate market growth over the forecast period. Furthermore, rising disposable income leading to increasing affordability of ventilators will accelerate the segment growth in the coming years.

Homecare segment will grow at a robust rate of around 10.5% over the forecast period owing to increasing demand for technologically advanced products that are portable, patient-friendly and easy to operate. Increasing preference of homecare to reduce hospital costs as well as hospital acquired infections will fuel the segment growth.

Request a discount on standard prices of this premium report at https://www.marketstudyreport.com/check-for-discount/467771/

U.S. therapeutic respiratory devices market accounted for the highest revenue of USD 3.8 billion in 2017 owing to the availability of developed healthcare facilities and technological advancements. Rising incidences of chronic respiratory diseases coupled with increasing geriatric population base will augment the market growth. Moreover, increased smoking, lifestyle changes and other environmental factors will further fuel the demand for therapeutic respiratory devices over the forecast period.

Some of the notable industry players of global therapeutic respiratory devices market are Aircep Corporation, Breas Medical, CareFusion Corporation, Compumedics, Fisher & Paykel, GE Healthcare, Hamilton Medical, Hill-Rom, Inogen, Invacare, Medtronic, Mindray Medical, Philips Healthcare, Resmed, Smiths Medical and Teleflex. Major players are primarily emphasizing on developing novel technologies to diversify their product portfolio. They are also focusing on partnerships, mergers and acquisitions to enhance the product portfolio and maintain their market position.

Table of Contents

Chapter 3. Therapeutic Respiratory Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 - 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Rising prevalence of respiratory diseases in developing countries
3.3.1.2. Increasing geriatric population globally
3.3.1.3. Technological innovation in developed countries
3.3.2. Industry pitfalls & challenges
3.3.2.1. Lack of patient compliance
3.3.2.2. Cost burden of respiratory diseases
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By end-use
3.5. Technology landscape
3.6. Regulatory landscape
3.6.1. U.S.
3.6.2. Europe
3.6.3. China
3.7. Porter's analysis
3.8. Competitive landscape,2017
3.8.1. Strategy dashboard
3.9. PESTEL analysis

Chapter 4. Therapeutic Respiratory Devices Market, By Product
4.1. Key segment trends
4.2. Obstructive sleep apnea (OSA) devices
4.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.2. Positive airway pressure (PAP) devices
4.2.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.2.2. Continuous positive airway pressure (CPAP) devices
4.2.2.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.2.3. Auto-titrating positive airway pressure (APAP) devices
4.2.2.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.2.4. Bi-level positive airway pressure (BPAP) devices
4.2.2.4.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.3. Oxygen concentrators
4.2.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.3.2. Fixed oxygen concentrators
4.2.3.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.3.3. Portable oxygen concentrators
4.2.3.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.4. Adaptive servo-ventilators (ASV)
4.2.4.1. Market size, by region, 2013 - 2024 (USD Million)
4.2.5. Others
4.2.5.1. Market size, by region, 2013 - 2024 (USD Million)
4.3. Ventilators
4.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.3.2. Adult ventilators
4.3.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.3.3. Neonatal ventilators
4.3.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.4. Inhalers
4.4.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.2. Nebulizers
4.4.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.2.2. Compressor-based nebulizers
4.4.2.2.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.2.3. Piston-based hand-held nebulizers
4.4.2.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.2.4. Ultrasonic nebulizers
4.4.2.4.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.3. Metered dose inhalers (MDI)
4.4.3.1. Market size, by region, 2013 - 2024 (USD Million)
4.4.4. Dry powder inhalers (DPI)
4.4.4.1. Market size, by region, 2013 - 2024 (USD Million)
4.6.1. Market size, by region, 2013 - 2024 (USD Million)

For more information on this report, Please visit at: https://www.marketstudyreport.com/reports/therapeutic-respiratory-devices-market

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email:sales@marketstudyreport.com
Website:https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.